Insempra and BII collaborate to accelerate biotech innovation

30.01.2023 · 3 min. read

, Linkedin, Twitter

Munich, 30th November 2022, Insempra, a biology-powered company enabling businesses to make superior products with nature, today announces its new collaboration with the BioInnovation Institute (BII) to accelerate and support biotech innovation.

The collaboration between Insempra and the BioInnovation Institute (BII) will help identify early-stage innovation and technology to advance the development of sustainable solutions for the benefit of people, society and the planet.

Insempra will support the collaboration by mentoring BII portfolio companies and advising early-stage startups within the synthetic biology space. BII will open their network of investors and stakeholders to Insempra, which will help accelerate scouting new technologies to support the company’s mission to develop superior ingredients for wide-scale market application.

“We are honored to be one of the BII’s few selected industry collaborators and look forward to the new opportunities this collaboration will bring to advance innovation within our field. By advising and mentoring BII’s early-stage portfolio companies, we will have the opportunity to start a dialogue with some of the most exciting innovators working towards the same vision as Insempra to drive the regenerative revolution for a better future.” Jens Klein, CEO and Founder of Insempra comments.

Insempra and its team of experienced biologists, entrepreneurs and commercial experts has extensive knowledge in scaling and commercializing biotech and will share this knowledge with BII portfolio companies throughout the collaboration to facilitate joint action for a more sustainable future.

“The collaboration between BII and Insempra is founded on a mutual vision for a sustainable future. With BII’s strategic focus as a non-profit foundation supporting early-stage start-ups that improve planetary health and Insempra’s mission to manufacture at scale in collaboration with nature, we look forward to the synergies we can create and the value this collaboration can bring.” Senior Business Developer at BII, Christian Brix Tillegreen, added.


About Insempra

Insempra is a biology-powered company enabling businesses to make superior products with nature. We combine bioscience and technology to grow matter for new and better products.

For too long, businesses have relied on chemical industrialization processes and petrochemicals, depleting our planet’s limited resources. That’s why we are committed to driving the regenerative revolution to manufacture at scale in collaboration with nature.

Led by a hand-picked team of biologists, technologists and entrepreneurs with rebel hearts, Insempra is here to create a new school of thought and collective action. The time to restore the balance between people and the planet is now. We don’t wait for change. We do what needs to be done to grow a better future.

About BioInnovation Institute

The BioInnovation Institute Foundation (BII) is an international commercial foundation with a non-profit objective. BII operates an incubator to accelerate world-class life science innovation.

Our vision is to support world-class life science innovation that drives the development of new solutions by early life science start-ups for the benefit of people and society.

With continued positive development, The Novo Nordisk Foundation can provide up to EUR 470 (3,5 mia. DKK) to BII over 10 years.

Learn more about BII at bii.dk


Enquiries

FTI Consulting

Ann Bartling / Michael Trace

Tel: +44/(0)20/3727 1000

insempra@fticonsulting.com

Posted by Nicole Laurence

Latest news

Meet Tim Zeiske, Head of Data Science, Innovation & Automation Lipids

Meet Tim Zeiske, Insempra's Head of Data Science, Innovation & Automaton Lipids
Cell-Free Technology established at Insempra

Cell-Free Technology established at Insempra

Scent, flavor, color, and other properties are what make our favorite food and personal care products particularly special. Increasingly, these ingredients come from exploitative processes. At Insempra we build microbial strains that can convert renewable feedstocks to natural ingredients by precision fermentation - a natural process that is non-exploitative.
Insempra appoints two new members to its Scientific Advisory Board

Insempra appoints two new members to Scientific Advisory Board

Insempra today announces the appointment of Professor Michael Jewett, PhD and Professor Paul Freemont to its scientific advisory board (SAB). The SAB is comprised of world-renowned academics to provide scientific review and high-level counsel on the Company’s R&D to advance its development of intrinsically sustainable ingredients at scale. 

Meet Luisa Gronenberg, Head of R&D for Functional Ingredients & Strain Engineering

Meet Luisa Gronenberg, Insempra's Head of R&D for Functional Ingredients & Strain Engineering.

10 things Insempra looks for when scouting new tech

Finding partners that are a good fit for Insempra’s model means analyzing loads of academic institutions, SMEs, start-ups and innovative business units at corporations. We have created a framework of ten criteria to evaluate new technologies in order to make decisions more quickly. We use this framework while looking for new potential partners and collaborators.

Meet Dr. Volker Wagner-Solbach, Head of Scale Up, Supply Chain & Procurement

Meet Dr. Volker Wagner-Solbach, Insempra's Head of Scale Up, supply chain and procurement.

Q&A with Jens Klein, CEO & Founder of Insempra

Meet Jens Klein, CEO & Founder of Insempra
Insempra Fibers

Insempra, formerly Origin.Bio, announces strategic investment in Solena Materials

Strategic investment to support the foundation of Solena Materials, a spin-out from Imperial College London, accelerating the development of synthetic fibers for high-performance, intrinsically sustainable clothing

Origin.bio and Carbocycle join forces to revolutionize the chemical industry towards a regenerative future

Origin.bio, a biotechnology company, and the team of Carbocycle, a spin-off from Columbia University, are joining forces to produce tailor-made lipids torevolutionize the chemical industry towards a regenerative future.

This Company Is Freeing Manufacturers From Petrochemicals With Biology

Origin.Bio announced today that it has secured $15 million of funding led by EQT Ventures. The company plans to use the funding to expand technology and bring sustainable ingredients to brands all over the world.

Nature grows
— and so does our community.

Read more